Mayo Clinic Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 First Street SW, Rochester, MN 55905, USA.
Immunogenetics. 2010 Apr;62(4):197-210. doi: 10.1007/s00251-010-0423-6. Epub 2010 Mar 10.
An effective immune response to vaccination is, in part, a complex interaction of alleles of multiple genes regulating cytokine networks. We conducted a genotyping study of Th1/Th2/inflammatory cytokines/cytokine receptors in healthy children (n = 738, 11-19 years) to determine associations between individual single-nucleotide polymorphisms (SNPs)/haplotypes and immune outcomes after two doses of rubella vaccine. SNPs (n = 501) were selected using the ldSelect-approach and genotyped using Illumina GoldenGate and TaqMan assays. Rubella-IgG levels were measured by immunoassay and secreted cytokines by ELISA. Linear regression and post hoc haplotype analyses were used to determine associations between single SNPs/haplotypes and immune outcomes. Increased carriage of minor alleles for the promoter SNPs (rs2844482 and rs2857708) of the TNFA gene were associated with dose-related increases in rubella antibodies. IL-6 secretion was co-directionally associated (p < or = 0.01) with five intronic SNPs in the TNFRSF1B gene in an allele dose-related manner, while five promoter/intronic SNPs in the IL12B gene were associated with variations in IL-6 secretion. TNFA haplotype AAACGGGGC (t-statistic = 3.32) and IL12B promoter haplotype TAG (t-statistic = 2.66) were associated with higher levels of (p < or = 0.01) rubella-IgG and IL-6 secretion, respectively. We identified individual SNPs/haplotypes in TNFA/TNFRSF1B and IL12B genes that appear to modulate immunity to rubella vaccination. Identification of such "genetic fingerprints" may predict the outcome of vaccine response and inform new vaccine strategies.
接种疫苗产生有效免疫应答在一定程度上是多个基因调节细胞因子网络的等位基因之间复杂相互作用的结果。我们对健康儿童(n = 738,11-19 岁)进行了 Th1/Th2/炎症细胞因子/细胞因子受体的基因分型研究,以确定风疹疫苗接种后两剂后个体单核苷酸多态性(SNP)/单倍型与免疫结果之间的关联。使用 ldSelect 方法选择 SNP(n = 501),并使用 Illumina GoldenGate 和 TaqMan 测定法进行基因分型。通过免疫测定法测量风疹 IgG 水平,通过 ELISA 测量分泌的细胞因子。使用线性回归和事后单倍型分析来确定单个 SNP/单倍型与免疫结果之间的关联。TNFA 基因启动子 SNP(rs2844482 和 rs2857708)的次要等位基因携带增加与风疹抗体剂量相关增加有关。IL-6 分泌与 TNFRSF1B 基因中五个内含子 SNP 呈共向相关(p≤0.01),呈等位基因剂量相关,而 IL12B 基因中五个启动子/内含子 SNP 与 IL-6 分泌的变化相关。TNFA 单倍型 AAACGGGGC(t 统计量=3.32)和 IL12B 启动子单倍型 TAG(t 统计量=2.66)与风疹 IgG 和 IL-6 分泌的较高水平相关(p≤0.01),分别。我们确定了 TNFA/TNFRSF1B 和 IL12B 基因中的个体 SNP/单倍型,这些 SNP/单倍型似乎调节了风疹疫苗接种的免疫应答。识别此类“遗传指纹”可以预测疫苗反应的结果,并为新的疫苗策略提供信息。